Estimating antiviral effectiveness against pandemic influenza using household data

Journal of the Royal Society Interface

Volumn 6, Issue 37, 2009, Pages 695-703

  Glass, Kathryn ^a   Becker, Niels G ^a  

^a The Australian National University   (Australia)

Author keywords

Antiviral drugs; Estimation; Influenza; Pandemic; Transmission model

Indexed keywords

ESTIMATION;

ANTIVIRAL DRUGS; ANTIVIRALS; ASYMPTOMATIC INFECTION; CURRENT ESTIMATES; INFLUENZA; PANDEMIC; PANDEMIC INFLUENZA; PANDEMIC STRAINS; SIGNIFICANT IMPACTS; TRANSMISSION MODEL;

STRAIN;

ANTIVIRUS AGENT;

ARTICLE; HOUSEHOLD; HUMAN; INFLUENZA; PANDEMIC; SENSITIVITY ANALYSIS; VIRUS TRANSMISSION;

EID: 67650996980     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2008.0404     Document Type: Article

References (20)

1. Bailey, N. J. T. 1975 The mathematical theory of infectious diseases and its applications. London, UK: Griffin.
2. Barnes, B. & Glass, K. 2007 The role of health care workers and antiviral drugs in the control of pandemic influenza. Math. Biosci. 209, 403-416. (doi:10.1016/j.mbs.2007. 02.008)
3. Cheng, M. H. 2005 Flu, what flu. Lancet Infect. Dis. 5, 746. (doi:10.1016/S1473-3099(05)70290-5)
4. Esveld, M. 2006 Influenza as an issue on the agenda of policy makers and government representatives. What can we do? What do we need? Vaccine 24, 6793-6795. (doi:10. 1016/j.vaccine.2006.06.068)
5. Ferguson, N. M., Cummings, D. A. T., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S. & Burke, D. S. 2005 Strategies for containing an emerging influenza pandemic in southeast Asia. Nature 437, 209-214. (doi:10.1038/nature04017) (Pubitemid 41294478)
6. Halloran, M. E., Hayden, F. G., Yang, Y., Longini, I. M. & Monto, A. S. 2006 Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am. J. Epidemiol. 165, 212-221. (doi:10.1093/aje/kwj362)
7. Harrod, M. E., Emery, S. & Dwyer, D. E. 2006 Antivirals in the management of an influenza pandemic. Med. J. Aust. 185, S58-S61.
8. Hayden, F. G., Treanor, J. J., Betts, R. F., Lobo, M., Esinhart, J. D. & Hussey, E.K. 1996 Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. J. Am. Med. Assoc. 275, 295-299. (doi:10.1001/jama.275.4.295)
9. Hayden, F. G. et al. 1997 Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N. Engl. J. Med. 337, 874-880. (doi:10.1056/NEJM199709253371302)
10. Hayden, F. G. et al. 1999 Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza. J. Am. Med. Assoc. 282, 1240-1246. (doi:10.1001/jama. 282.13.1240)
11. Hayden, F. G., Gubareva, L. V., Monto, A. S., Klein, T. C., Elliott, M. J., Hammond, J. M., Sharp, S. J. & Ossi, M. J. 2000 Inhaled zanamivir for the prevention of influenza in families. N. Engl. J. Med. 343, 1282-1289. (doi:10.1056/ NEJM200011023431801)
12. Hayden, R. G., Belshe, R., Villanueva, C., Lanno, R., Hughes, C., Small, I., Dutkowski, R., Ward, P. & Carr, J. 2004 Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J. Infect. Dis. 189, 440-449. (doi:10.1086/381128)
13. Jefferson, T., Demicheli, V., Rivetti, D., Jones, M., Pietrantonj, C. D. & Rivetti, A. 2006 Antivirals for influenza in healthy adults: systematic review. Lancet 367, 303-313. (doi:10.1016/S0140-6736(06)67970-1) (Pubitemid 43151463)
14. Lett, D. 2005 Feds to stockpile antivirals as pandemic "speed bump". Can. Med. Assoc. J. 172, 1167. (doi:10. 1503/cmaj.050332)
15. Longini, I. M., Nizam, A., Xu, S., Ungchusak, K., Hanshaoworakul, W., Cummings, D. A. T. & Halloran, M. E. 2005 Containing pandemic influenza at the source. Science 309, 1083-1087. (doi:10.1126/science.1115717)
16. McCaw, J. M. & McVernon, J. 2007 Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Math. Biosci. 208, 336-360. (doi:10.1016/j.mbs.2007.02.003)
17. Monto, A. S., Pichichero, M. E., Blanckenberg, S. J., Ruuskanen, O., Cooper, C., Fleming, D. M. & Kerr, C. 2002 Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. J. Infect. Dis. 186, 1582-1588. (doi:10.1086/345722)
18. Nicholson, K. G., Aoki, F. Y., Osterhaus, A., Trottier, S., Carewicz, O., Mercier, D. H., Rode, A., Kinnersley, N. & Ward,P. 2000Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 355, 1845-1850. (doi:10.1016/S0140-6736(00)02288-1)
19. Treanor, J. J. et al. 2000 Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza. J. Am. Med. Assoc. 283, 1016-1024. (doi:10. 1001/jama.283.8.1016)
20. Welliver, R. et al. 2001 Effectiveness of oseltamivir in preventing influenza in household contacts. J. Am. Med. Assoc. 285, 748-756. (doi:10.1001/jama.285.6.748)